| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/17/1997 | CN1168103A Dermatological use of vitamin D derivs. |
| 12/17/1997 | CN1168102A Resin particle, medical material and pharmaceutical preparation contg. said resin particle |
| 12/17/1997 | CN1168101A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of cerebral degenerative disorders |
| 12/17/1997 | CN1168100A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for vasodilatory treatment or prophylaxis |
| 12/17/1997 | CN1168099A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of obesity |
| 12/17/1997 | CN1168098A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of hyperlipopropteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia |
| 12/17/1997 | CN1168097A Use of 3,4-diphenyl chromans for manufacture of pharmaceutical composition for treatment or prophylaxis of idiopathic or physiologic gynaecomastia |
| 12/17/1997 | CN1168096A Use of 3,4-diphenyl chromans for mfg. pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
| 12/17/1997 | CN1168095A Treatment of attention-deficit/hyperactivity disorder |
| 12/17/1997 | CN1168094A Directly compressible high load acetaminophen formulations |
| 12/17/1997 | CN1167777A Interferon conjugates |
| 12/17/1997 | CN1167765A Process for isolating or purifying cefonicid and process for preparing salts thereof |
| 12/17/1997 | CN1167763A Acids and esters of diosmetin and pharmaceutical compositions containing them |
| 12/17/1997 | CN1167762A Tetrahydroisoquinoline derivatives and their use |
| 12/17/1997 | CN1167759A Substd. 2-naphthoyl guanidines, their preparing method, use and drug contg. them |
| 12/17/1997 | CN1167758A Substd. 1-naphthoyl guanidines, their preparing method, use and drug contg. them |
| 12/17/1997 | CN1167752A Novel retinoids derivs. |
| 12/17/1997 | CN1167618A Anti-beta-lactamase antibiotic composition |
| 12/17/1997 | CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 12/17/1997 | CN1167616A Use of octopirox as depigmenting agent |
| 12/17/1997 | CN1167567A Bacteriocidal antibacterial and bacteriostatic composition |
| 12/17/1997 | CN1036719C Preparation process for 20-oxo-17 alpha, 21-dihydroxylated derivs. of pregnane |
| 12/17/1997 | CN1036718C Method for preparing 19-demethyl steroid compound having thiocarbon chain at 11-beta position |
| 12/17/1997 | CN1036714C Crystalline carbapenem deriv. |
| 12/17/1997 | CN1036713C Carbapenem deriv., its intermediate, preparing process and medicine composition contg. it |
| 12/17/1997 | CN1036712C Process for preparation of £1R-(1alpha, 2beta, 3alpha)|-2-amino-9-£2,3-di(hydroxymethyl)-cyclobutyl|-1,9-dihydro-6H-purin-6-one as antiviral agent |
| 12/17/1997 | CN1036711C Process for preparation of imidazoindolizine derivs. |
| 12/17/1997 | CN1036699C Silica ketoconazole ointment and its preparing method |
| 12/17/1997 | CA2207943A1 Therapeutic agent for joint diseases |
| 12/16/1997 | US5698786 Sensing apparatus for generating an output signal |
| 12/16/1997 | US5698733 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 12/16/1997 | US5698721 Catonic amphiphiles |
| 12/16/1997 | US5698706 Heterocyclic amides and methods of use |
| 12/16/1997 | US5698698 Process for preparation of N-tert.butyl-decahydro-2- 2(R)-hydroxy-4-phenyl-3(S)-phthalimidobutyl!-(4aS,8aS)-isoquinoline-3(S)-carboxamide |
| 12/16/1997 | US5698692 Inhibit binding between platelet membrane glycoprotein and fibrinogen |
| 12/16/1997 | US5698691 Condensed cyclic compounds and their use |
| 12/16/1997 | US5698690 Hydroxamic acid derivatives with tricyclic substitution |
| 12/16/1997 | US5698687 Rna molecule containing modified nucloside |
| 12/16/1997 | US5698598 EP2 -receptor agonists as agents for lowering intraocular pressure |
| 12/16/1997 | US5698596 Substituted benzenesulfonylureas and thioureas process for their preparation and their use as pharmaceuticals |
| 12/16/1997 | US5698595 Use of sulfonic acids as anti-ageing agents in a cosmetic or dermatological composition |
| 12/16/1997 | US5698594 Treatment and prevention of risk factors for cardiovascular diseases |
| 12/16/1997 | US5698593 Method for treating acne |
| 12/16/1997 | US5698590 Treatment of peripheral circulatory disorders and ulcers and for blood flow maintenance after surgery |
| 12/16/1997 | US5698589 Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
| 12/16/1997 | US5698588 Optically pure enantiomeric form; treating central nervous system disorders |
| 12/16/1997 | US5698586 Angiogenesis inhibitory agent |
| 12/16/1997 | US5698585 For senile cataract caused by oxidation disorder; vision defects |
| 12/16/1997 | US5698582 Injectable solution; dissolved in polysorbate or polyethoxylated castor oil; ethanol-free |
| 12/16/1997 | US5698581 Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 12/16/1997 | US5698580 Antiviral agent containing benzodithiin derivative as active ingredient |
| 12/16/1997 | US5698579 Inhibitor of tumor necrosis factor |
| 12/16/1997 | US5698578 Protein kinase C inhibitors |
| 12/16/1997 | US5698577 Compositions of bicyclic β-lactams and uses thereof |
| 12/16/1997 | US5698576 Possess anti-ulcer and 5-lipoxygenase inhibitory activities |
| 12/16/1997 | US5698574 5-membered heteroaryl-oxazolidinones |
| 12/16/1997 | US5698573 Imidazolone and oxazolone derivatives as dopamine antagonists |
| 12/16/1997 | US5698572 Methods of inhibiting turner's syndrome |
| 12/16/1997 | US5698571 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| 12/16/1997 | US5698570 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime)pyrrolidine substituent and processes for preparing thereof |
| 12/16/1997 | US5698569 Viricide |
| 12/16/1997 | US5698568 Substance p antagonists |
| 12/16/1997 | US5698567 Heterocyclic spiro compounds |
| 12/16/1997 | US5698566 Nitrogen-containing spirocycles |
| 12/16/1997 | US5698565 Use of phenoxy-pyridine derivatives |
| 12/16/1997 | US5698562 Consisting of trimethoprim, purified water, hydrochloric acid to dissolve drug, sucrose, flavoring to overcome bitter taste; pediatric dosing |
| 12/16/1997 | US5698561 Medicament for treating or preventing cerebrovascular dementia |
| 12/16/1997 | US5698558 Methods for treating allergic disorders using optically pure (-) cetirizine |
| 12/16/1997 | US5698555 Hetaryloxy-β-carbolines, their production and use in pharmaceutical agents |
| 12/16/1997 | US5698554 Preventing and treating nephritis, endotoxic shock |
| 12/16/1997 | US5698553 Nervous system disorders |
| 12/16/1997 | US5698552 Hetrazepinoid amides |
| 12/16/1997 | US5698551 Treatment of diabetic neuropathy, migraines, neurogenic inflammation, rheumatic arthritis and insulin resistance |
| 12/16/1997 | US5698548 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 12/16/1997 | US5698546 Cyclic polyamines |
| 12/16/1997 | US5698545 Angiostatic steroids and methods and compositions for controlling ocular hypertension |
| 12/16/1997 | US5698542 Compound comprising tetracycline type antibiotic linked to steroid type hormone |
| 12/16/1997 | US5698541 2,4-diphosphonoglutaric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 12/16/1997 | US5698537 Administering phospholipids |
| 12/16/1997 | US5698536 Plasma-like substance |
| 12/16/1997 | US5698535 SIN-1A cyclodextrin inclusion complexes |
| 12/16/1997 | US5698534 Antiulcer agent and process for preparing the same |
| 12/16/1997 | US5698532 Pyrimidine nucleosides and methods for treating viral infections with same |
| 12/16/1997 | US5698526 Anticholesterol agent |
| 12/16/1997 | US5698524 Preparing water soluble reaction product polymer of lignin and lignoid that have each been extracted from wood or wood-like materials under acidic and/or alkaline conditions |
| 12/16/1997 | US5698523 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 12/16/1997 | US5698445 Human PAK65 |
| 12/16/1997 | US5698439 Novel malignant cell type markers of the interior nuclear matrix |
| 12/16/1997 | US5698428 Human PAK65 |
| 12/16/1997 | US5698405 Coupling immunogenic agent with a carbohydrate polymer |
| 12/16/1997 | US5698404 Method of predicting fetal membrane rupture based on pro-matrix metalloproteinase-9 (pro-mmp-9) |
| 12/16/1997 | US5698392 Nucleic acid fragments and diagnostic reagents derived from the HHV6/SIE genome and procedures for diagnosing HHV6 infections |
| 12/16/1997 | US5698244 Method for raising animals having high concentrations of omega-3 highly unsaturated fatty acids |
| 12/16/1997 | US5698230 Nutrition |
| 12/16/1997 | US5698226 Water-dispersible tablets |
| 12/16/1997 | US5698225 A core of nonsteroidal anti-inflammatory antiarthritic agent surrounded by coatings comprising misoprostol an anti-ulcer agent for side effect reduction; drug delivery |
| 12/16/1997 | US5698224 Osmotic dosage form |
| 12/16/1997 | US5698221 Containing 2-amino-2-(4-methylpiperazin-1-ylzzzz0-5-(2,3,5-trichlorophen yl)pyrimidine |
| 12/16/1997 | US5698219 Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof |
| 12/16/1997 | US5698217 Transdermal drug delivery device containing a desiccant |